GSK Hits Consumer Brand Divestment Target As Q3 Performance Mixed

29 Oct 2020

GSK's Brian McNamara says the firm has hit its £1bn brand divestment target which will help fund the restructuring of its Consumer Healthcare business before it is spun off in 2022.

Munich, Bavaria / Germany - May 19, 2018: Headquarters of GlaxoSmithKline GmbH & Co. KG in Munich, Germany - GSK is a British pharmaceutical company — • Source: Shutterstock

GlaxoSmithKline plc is almost done reshaping its enlarged Consumer Healthcare portfolio, with the company revealing it has hit its £1.0bn ($1.3bn) brand divestment target for the business.

Speaking as the UK-based pharma giant announced its third-quarter results, Brian McNamara, GSK Consumer Healthcare CEO, said the company had...